Dr John James Moore
Conjoint Associate Professor

Dr John James Moore

MB.BS, MD, FRACP, FRCPA

medicine-health
St Vincent's Clinical School
Phone
+61 2 93555656
Location
Kinghorn Cancer Centre 370 Victoria Rd Darlinghurst NSW, 2010 Australia

Publications

  • Journal articles | 2021
    Dr John James Moore
    Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, vol. 72, pp. 1141 - 1146, http://dx.doi.org/10.1093/cid/ciaa748
    Journal articles | 2021
    Dr John James Moore
    McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, vol. 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9
    Journal articles | 2021
    Dr John James Moore
    Blennerhassett R; Moses JH; Coulits N; Horne A; Simpson J; Marshall J; Weston L; Moore J, 2021, 'Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele', Bone Marrow Transplantation, http://dx.doi.org/10.1038/s41409-021-01402-x
    Journal articles | 2021
    Dr John James Moore
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2021, 'Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors', Journal of Psychosocial Oncology, vol. 39, pp. 534 - 552, http://dx.doi.org/10.1080/07347332.2020.1870644
    Journal articles | 2021
    Dr John James Moore
    Kennedy GA; Tey SK; Buizen L; Varelias A; Gartlan KH; Curley C; Olver SD; Chang K; Butler JP; Misra A; Subramoniapillai E; Morton AJ; Durrant S; Henden AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Paul SK; Hill GR, 2021, 'A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis', Blood, vol. 137, pp. 1970 - 1979, http://dx.doi.org/10.1182/blood.2020009050
    Journal articles | 2021
    Dr John James Moore
    McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2021, 'Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-021-01038-2
    Journal articles | 2021
    Dr John James Moore
    Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, pp. 13524585211005660, http://dx.doi.org/10.1177/13524585211005660
    Journal articles | 2021
    Dr John James Moore
    McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, vol. 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
    Journal articles | 2020
    Dr John James Moore
    Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2020, 'An integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.14973
    Journal articles | 2020
    Dr John James Moore
    Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, vol. 55, pp. 681 - 694, http://dx.doi.org/10.1038/s41409-019-0718-7
    Journal articles | 2020
    Dr John James Moore
    Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA; Snowden J; McGrath E; Bambi F; Sanchez-Guijo F; Worel N; Badolglio M; Abinun M; Arnold R; Brierley C; Castilla-Llorente C; Cooper N; Daikeler T; del Papa N; Finke J; Reax R; Hagglund H; Henes J; Hiepe F; Kiely D; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Saif M; Sakellari I; Snarski E; Scherer HU; Sossa C; de Vries-Bouwstra J; Wulffraat N; Zaccara E, 2020, 'Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)', Bone Marrow Transplantation, vol. 55, pp. 283 - 306, http://dx.doi.org/10.1038/s41409-019-0684-0
    Journal articles | 2020
    Dr John James Moore
    Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)', Bone Marrow Transplantation, vol. 55, pp. 838 - 839, http://dx.doi.org/10.1038/s41409-019-0740-9
    Journal articles | 2020
    Dr John James Moore
    Hendrawan K; Visweswaran M; Ma DDF; Moore JJ, 2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, vol. 55, pp. 857 - 866, http://dx.doi.org/10.1038/s41409-019-0710-2
    Journal articles | 2020
    Dr John James Moore
    Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2020, 'Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study', European Journal of Oncology Nursing, vol. 49, http://dx.doi.org/10.1016/j.ejon.2020.101845
    Journal articles | 2020
    Dr John James Moore
    Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, vol. 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030
    Journal articles | 2020
    Dr John James Moore
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2020, 'Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial', The Lancet Haematology, vol. 7, pp. e100 - e111, http://dx.doi.org/10.1016/S2352-3026(19)30220-0
    Journal articles | 2020
    Dr John James Moore
    Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, vol. 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209
    Journal articles | 2020
    Dr John James Moore
    Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, vol. 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131
    Journal articles | 2020
    Dr John James Moore
    McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
    Journal articles | 2020
    Dr John James Moore
    Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2020, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.', Intern Med J, http://dx.doi.org/10.1111/imj.15072
    Journal articles | 2020
    Dr John James Moore
    Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; David DF; Milliken S; Moore J; Purtill D; Szer J, 2020, 'Effect of donor age on adult unrelated donor hematopoietic cell transplant outcome: the Australian experience.', Intern Med J, http://dx.doi.org/10.1111/imj.15128
    Journal articles | 2019
    Dr John James Moore
    Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446
    Journal articles | 2019
    Dr John James Moore
    Kennedy GA; Tey S-K; Curley C; Butler JP; Misra A; Subramoniapillai E; Morton J; Durrant S; Hendon AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Buizen L; Paul SK; Hill GR, 2019, 'Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation', Blood, vol. 134, pp. 368 - 368, http://dx.doi.org/10.1182/blood-2019-126285
    Journal articles | 2019
    Dr John James Moore
    Ismail A; Sharrack B; Saccardi R; Moore JJ; Snowden JA, 2019, 'Autologous haematopoietic stem cell therapy for multiple sclerosis: A review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation', Current Opinion in Supportive and Palliative Care, vol. 13, pp. 394 - 401, http://dx.doi.org/10.1097/SPC.0000000000000466
    Journal articles | 2019
    Dr John James Moore
    Jessop H; Farge D; Saccardi R; Alexander T; Rovira M; Sharrack B; Greco R; Wulffraat N; Moore J; Kazmi M; Badoglio M; Adams G; Verhoeven B; Murray J; Snowden JA, 2019, 'General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, vol. 54, pp. 933 - 942, http://dx.doi.org/10.1038/s41409-019-0430-7
    Journal articles | 2019
    Dr John James Moore
    Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I, 2019, 'A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia', Transplant Infectious Disease, vol. 21, http://dx.doi.org/10.1111/tid.13043
    Journal articles | 2019
    Dr John James Moore
    Saccardi R; Badoglio M; Burman J; Helbig G; Kazmi MA; Mancardi G; Mielke S; Moore J; Muraro P; Sanz J; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2019, 'BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', Blood, vol. 134, pp. 3313 - 3313, http://dx.doi.org/10.1182/blood-2019-125233
    Journal articles | 2019
    Dr John James Moore
    Roy J; Panzarella T; Couban S; Couture F; Devins GM; Elemary M; Foley SR; Gallagher G; Kuruvilla J; Lee SJ; Moore J; Nevill TJ; Popradi G; Schultz KR; Szwajcer D; Toze CL; Walker I, 2019, 'Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial', Blood, vol. 134, pp. 875 - 875, http://dx.doi.org/10.1182/blood-2019-123275
    Journal articles | 2019
    Dr John James Moore
    McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, vol. 51, pp. S92 - S92, http://dx.doi.org/10.1016/j.pathol.2018.12.243
    Journal articles | 2018
    Dr John James Moore
    Dyer G; Brice L; Schifter M; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in Australia', Australian Dental Journal, vol. 63, pp. 312 - 319, http://dx.doi.org/10.1111/adj.12627
    Journal articles | 2018
    Dr John James Moore
    Ma CKK; García-Cadenas I; Fox ML; Ai S; Nivison-Smith I; Milliken ST; Dodds A; Fay K; Ma DDF; Martino R; Sierra J; Moore J, 2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, vol. 53, pp. 1478 - 1482, http://dx.doi.org/10.1038/s41409-018-0215-4
    Journal articles | 2018
    Dr John James Moore
    Dyer G; Brice L; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia', Bone Marrow Transplantation, vol. 53, pp. 926 - 931, http://dx.doi.org/10.1038/s41409-018-0098-4
    Journal articles | 2018
    Dr John James Moore
    Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie D, 2018, 'Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse', Internal Medicine Journal, vol. 48, pp. 276 - 285, http://dx.doi.org/10.1111/imj.13522
    Journal articles | 2018
    Dr John James Moore
    Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, vol. 9, http://dx.doi.org/10.3389/fimmu.2018.00410
    Journal articles | 2018
    Dr John James Moore
    Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA, 2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, vol. 40, pp. 533 - 539, http://dx.doi.org/10.1111/ijlh.12857
    Journal articles | 2018
    Dr John James Moore
    Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Udara PHSP; Siriwardena PPR; Milliken S; Ma DDF; Moore J, 2018, 'Working together: Establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka', Blood Advances, vol. 2, pp. 46 - 49, http://dx.doi.org/10.1182/bloodadvances.2018GS110686
    Journal articles | 2017
    Dr John James Moore
    Snowden JA; Badoglio M; Labopin M; Giebel S; McGrath E; Marjanovic Z; Burman J; Moore J; Rovira M; Wulffraat NM; Kazmi M; Greco R; Snarski E; Kozak T; Kirgizov K; Alexander T; Bader P; Saccardi R; Farge D, 2017, 'Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases', Blood Advances, vol. 1, pp. 2742 - 2755, http://dx.doi.org/10.1182/bloodadvances.2017010041
    Journal articles | 2017
    Dr John James Moore
    Bradstock KF; Link E; Iulio JD; Szer J; Marlton P; Wei AH; Enno A; Schwarer A; Lewis ID; D’Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn U; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson W; Hertzberg M; Deveridge S; Rowlings P; Mills AK; Gill D; Bardy P; Campbell L; Seymour JF, 2017, 'Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemia', Journal of Clinical Oncology, vol. 35, pp. 1678 - 1685, http://dx.doi.org/10.1200/JCO.2016.70.6374
    Journal articles | 2017
    Dr John James Moore
    Smith J; Poon C; Gilroy N; Kabir M; Brice L; Dyer G; Hogg M; Greenwood M; Moore J; Hertzberg M; Brown L; Tan J; Huang G; Kwan J; Larsen S; Ward C; Kerridge I, 2017, 'Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia', Supportive Care in Cancer, vol. 25, pp. 137 - 144, http://dx.doi.org/10.1007/s00520-016-3398-5
    Journal articles | 2017
    Dr John James Moore
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I, 2017, 'Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?', Supportive Care in Cancer, vol. 25, pp. 421 - 427, http://dx.doi.org/10.1007/s00520-016-3418-5
    Journal articles | 2016
    Dr John James Moore
    Dyer G; Larsen SR; Gilroy N; Brice L; Greenwood M; Hertzberg M; Kabir M; Brown L; Hogg M; Huang G; Moore J; Gottlieb D; Kwan J; Tan J; Ward C; Kerridge I, 2016, 'Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)', Cancer Medicine, vol. 5, pp. 1702 - 1716, http://dx.doi.org/10.1002/cam4.729
    Journal articles | 2016
    Dr John James Moore
    Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Moore J; Greenwood M; Hertzberg M; Gottlieb D; Larsen SR; Hogg M; Brown L; Huang G; Tan J; Ward C; Kerridge I, 2016, 'Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia', Cancer Medicine, vol. 5, pp. 3606 - 3614, http://dx.doi.org/10.1002/cam4.889
    Journal articles | 2016
    Dr John James Moore
    Rebeiro P; Moore J, 2016, 'The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders', Internal Medicine Journal, vol. 46, pp. 17 - 28, http://dx.doi.org/10.1111/imj.12944
    Journal articles | 2016
    Dr John James Moore
    Gifford G; Gilroy N; Dyer G; Brice L; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Kwan J; Huang G; Tan J; Brown L; Hogg M; Ward C; Kerridge I, 2016, 'The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', Bone Marrow Transplantation, vol. 51, pp. 1361 - 1368, http://dx.doi.org/10.1038/bmt.2016.135
    Journal articles | 2016
    Dr John James Moore
    Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simões B; Snowden JA; Farge D, 2016, 'Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?', Bone Marrow Transplantation, vol. 51, pp. 501 - 505, http://dx.doi.org/10.1038/bmt.2015.299
    Journal articles | 2016
    Dr John James Moore
    Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, 'What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia', Biology of Blood and Marrow Transplantation, vol. 22, pp. 731 - 743, http://dx.doi.org/10.1016/j.bbmt.2015.12.019
    Journal articles | 2016
    Dr John James Moore
    Dyer G; Gilroy N; Bradford J; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2016, 'A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', British Journal of Haematology, vol. 172, pp. 592 - 601, http://dx.doi.org/10.1111/bjh.13872
    Journal articles | 2016
    Dr John James Moore
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2016, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, vol. 17, pp. 164 - 173, http://dx.doi.org/10.1016/S1470-2045(15)00462-3
    Journal articles | 2016
    Dr John James Moore
    Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simoes B; Snowden JA; Farge D, 2016, 'Erratum: Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? (Bone Marrow Transplantation (2016) 51 (501-505) DOI: 10.1038/bmt.2015.299)', Bone Marrow Transplantation, vol. 51, pp. 889, http://dx.doi.org/10.1038/bmt.2016.126
    Journal articles | 2015
    Dr John James Moore
    Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF, 2015, 'Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: A non-randomised phase 2 trial', The Lancet Haematology, vol. 2, pp. e357 - e366, http://dx.doi.org/10.1016/S2352-3026(15)00115-5
    Journal articles | 2015
    Dr John James Moore
    Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A, 2015, 'Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice', Stem Cells and Development, vol. 24, pp. 724 - 736, http://dx.doi.org/10.1089/scd.2014.0230
    Journal articles | 2015
    Dr John James Moore
    Snarski E; Snowden JA; Oliveira MC; Simoes B; Badoglio M; Carlson K; Burman J; Moore J; Rovira M; Clark RE; Saiz A; Hadj-Khelifa S; Tan J; Crescimanno A; Musso M; Martin T; Farge D, 2015, 'Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: A retrospective study of the EBMT autoimmune diseases working party (ADWP)', Bone Marrow Transplantation, vol. 50, pp. 216 - 220, http://dx.doi.org/10.1038/bmt.2014.248
    Journal articles | 2015
    Dr John James Moore
    Alexander T; Bondanza A; Muraro PA; Greco R; Saccardi R; Daikeler T; Kazmi M; Hawkey C; Simoes BP; Leblanc K; Fibbe WE; Moore J; Snarski E; Martin T; Hiepe F; Velardi A; Toubert A; Snowden JA; Farge D, 2015, 'SCT for severe autoimmune diseases: Consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking', Bone Marrow Transplantation, vol. 50, pp. 173 - 180, http://dx.doi.org/10.1038/bmt.2014.251
    Journal articles | 2015
    Dr John James Moore
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2015, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, http://dx.doi.org/10.1016/S1470-2045(15)00462-3
    Journal articles | 2015
    Dr John James Moore
    Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ, 2015, 'Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors', Journal of Heart and Lung Transplantation, vol. 34, pp. 1406 - 1414, http://dx.doi.org/10.1016/j.healun.2015.05.021
    Journal articles | 2015
    Dr John James Moore
    Iland HJ; Collins M; Bradstock K; Supple S; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell L; Hugman A; Reynolds J; Di Lulio J; Campbell T; Taylor K; Filshie R; Seldon M; Tape J; Szer J; Moore JJ; Bashford J; Seymour JF, 2015, 'Impact of incorporating arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia: final analysis of th Australian Leukaemia and Lymphoma Group (ALLG) APML4 non-randomised phase II trial', Lancet (North American Edition), vol. 9, pp. e357 - e366
    Journal articles | 2014
    Dr John James Moore
    Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2014, 'Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', Internal Medicine Journal, vol. 44, pp. 287 - 290, http://dx.doi.org/10.1111/imj.12363
    Journal articles | 2014
    Dr John James Moore
    Khoo MLM; Carlin SM; Lutherborrow MA; Jayaswal V; Ma DDF; Moore JJ, 2014, 'Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells', Aging Cell, vol. 13, pp. 744 - 754, http://dx.doi.org/10.1111/acel.12229
    Journal articles | 2014
    Dr John James Moore
    Walker I; Schultz KR; Toze CL; Kerr HM; Moore J; Szwajcer D; Foley SR; Kuruvilla J; Panzarella T; Couture F; Roy J; Couban S; Devins G; Popradi G; Lee SJ; Tay J; Nevill TJ; Elemary M; Gallagher G, 2014, 'Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial', BLOOD, vol. 124, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349242702187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    Dr John James Moore
    Bryant A; Nivison-Smith I; Pillai ES; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil S; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearing R; Moore J, 2014, 'Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients', Bone Marrow Transplantation, vol. 49, pp. 17 - 23, http://dx.doi.org/10.1038/bmt.2013.142
    Journal articles | 2014
    Dr John James Moore
    Bilmon I; Nivison-Smith I; Hertzberg M; Ritchie D; Greenwood M; Spencer A; Kennedy G; Bryant A; Moore J, 2014, 'Outcomes following second allogeneic haematopoietic transplants using fludarabine–melphalan conditioning', Bone Marrow Transplantation, vol. 49, pp. 852 - 853, http://dx.doi.org/10.1038/bmt.2014.23
    Journal articles | 2013
    Dr John James Moore
    Carlin SM; Ma DD; Moore JJ, 2013, 'T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists', Cytotherapy, vol. 15, pp. 224 - 230, http://dx.doi.org/10.1016/j.jcyt.2012.10.014
    Journal articles | 2013
    Dr John James Moore
    Morrissey CO; Chen SC-A; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA, 2013, 'Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial', The Lancet Infectious Diseases, vol. 13, pp. 519 - 528, http://dx.doi.org/10.1016/S1473-3099(13)70076-8
    Journal articles | 2013
    Dr John James Moore
    Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V; Trappe RU, 2013, 'Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial', Leukemia, vol. 27, pp. 2102 - 2105, http://dx.doi.org/10.1038/leu.2013.110
    Journal articles | 2013
    Dr John James Moore
    Subramaniam K; Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2013, 'Immunosuppressive agents and the risk of hepatosplenic gamma delta-T cell lymphoma (HSTCL): Is the risk increased by concomitant use of anti-TNFs?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 28, pp. 95 - 96, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr John James Moore
    Zimmermann H; Choquet S; Dierickx D; Dreyling MH; Moore J; Valentin A; Striefler JK; Riess H; Leblond V; Trappe RU, 2013, 'Early and late posttransplant lymphoproliferative disorder after lung transplantation-34 cases from the European PTLD network', Transplantation, vol. 96, http://dx.doi.org/10.1097/TP.0b013e31829b0868
    Journal articles | 2013
    Dr John James Moore
    Snarski E; Snowden JA; Badoglio M; Carlson K; Burman J; Oliveira MC; Moore J; Tan J; Rovira M; Clark RE; Saiz A; Khelifa SH; Crescimanno A; Laing L; Musso M; Martin T; Farge D, 2013, 'Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)', Blood, vol. 122, pp. 4640 - 4640, http://dx.doi.org/10.1182/blood.v122.21.4640.4640
    Journal articles | 2012
    Dr John James Moore
    Snowden JA; Saccardi R; Allez M; Ardizzone S; Arnold R; Cervera R; Denton C; Hawkey C; Labopin M; Mancardi G; Martin R; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar JM; Farge D, 2012, 'Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European group for blood and marrow transplantation', Bone Marrow Transplantation, vol. 47, pp. 770 - 790, http://dx.doi.org/10.1038/bmt.2011.185
    Journal articles | 2012
    Dr John James Moore
    Carlin S; Khoo ML; Ma DD; Joseph JE, 2012, 'Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage', PLoS ONE, vol. 7, pp. e45342, http://dx.doi.org/10.1371/journal.pone.0045342
    Journal articles | 2012
    Dr John James Moore
    Mollee P; Tiley C; Cunningham I; Moore JJ; Prince M, 2012, 'A Phase II study of risk-adapted intravenous Melphalan in patiens with AL Amyloidosis', British Journal of Haematology, vol. 157, pp. 766 - 769, http://dx.doi.org/10.1111/j.1365-2141.2012.09080.x
    Journal articles | 2012
    Dr John James Moore
    Iland ; Bradstock K; Supple S; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore JJ; Bashford J; Seymour JF, 2012, 'All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)', Blood, vol. 120, pp. 1570 - 1580, http://dx.doi.org/10.1182/blood-2012-02-410746
    Journal articles | 2012
    Dr John James Moore
    Chih S; Mcdonald PS; Mccrohon JA; Ma DD; Moore JJ; Feneley MP; Law MG; Kovacic JC; Graham RM, 2012, 'Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: A placebo-controlled crossover trial.', Heart, vol. 98, pp. 282 - 290, http://dx.doi.org/10.1136/heartjnl-2011-300751
    Journal articles | 2012
    Dr John James Moore
    Moore J; Englert H; Furlong T; Poon T; Milliken S; Ma D, 2012, 'Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, vol. 47, pp. 1486 - 1487, http://dx.doi.org/10.1038/bmt.2012.67
    Journal articles | 2012
    Dr John James Moore
    Snowden J; Saccardi R; Allez M; Ardizzone S; Arnold RH; Cervera R; Denton CP; Hawkey CJ; Labopin M; Mancardi GL; Martin RP; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar J; Farge D, 2012, 'Haematopoietic stem cell transplanation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow transplatation (EBMT)', Bone Marrow Transplantation, vol. 47, pp. 770 - 790
    Journal articles | 2012
    Dr John James Moore
    Moore JJ; Englert H; Furlong TJ, 2012, 'Stem cell transplant induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, vol. 47, pp. 1486 - 1487
    Journal articles | 2011
    Dr John James Moore
    Nivison-Smith I; Dodds AJ; Dunkley H; Ma DD; Moore JJ; Simpson M; Szer J; Bradstock KF, 2011, 'Increased activity and improved outcome in unrelatred donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005', Internal Medicine Journal, vol. 41, pp. 27 - 34, http://dx.doi.org/10.1111/j.1445-5994.2010.02262.x
    Journal articles | 2011
    Dr John James Moore
    Mollee P; Tiley C; Cunningham I; Moore J; Prince M; Cannell P; Gibbons S; Tate J; Paul S; Gill DS, 2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,', Blood, vol. 118, pp. 3973 - 3973, http://dx.doi.org/10.1182/blood.v118.21.3973.3973
    Journal articles | 2011
    Dr John James Moore
    Bryant AJ; Pillai E; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil SS; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearling R; Nivison-Smith I; Moore J, 2011, 'A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008,', Blood, vol. 118, pp. 4143 - 4143, http://dx.doi.org/10.1182/blood.v118.21.4143.4143
    Journal articles | 2010
    Dr John James Moore
    Sasson SC; Smith S; Seddiki N; Zaunders J; Bryant AJ; Koelsch KK; Weatherall CJ; Munier CM; McGinley C; Yeung J; Mulligan S; Moore JJ; Cooper DA; Milliken ST; Kelleher AD, 2010, 'IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers', Cytokine, vol. 50, pp. 58 - 68, http://dx.doi.org/10.1016/j.cyto.2009.12.001
    Journal articles | 2010
    Dr John James Moore
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases', Haematologica, vol. 95, pp. 284 - 292, http://dx.doi.org/10.3324/haematol.2009.013458
    Journal articles | 2010
    Dr John James Moore
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Moore JJ; Kozak T; Kotter I; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Haematologica, vol. 95, pp. 284 - 292
    Journal articles | 2009
    Dr John James Moore
    Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2009, 'Hepatosplenic T cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A314 - A314, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2008
    Dr John James Moore
    Englert H; Kirkham S; Moore JJ; Poon T; Katelaris C; McGill N; Schrieber L; Manolios N, 2008, 'Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function', Internal Medicine Journal, vol. 38, pp. 692 - 696, http://dx.doi.org/10.1111/j.1445-5994.2007.01593.x
    Journal articles | 2008
    Dr John James Moore
    Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Freund J; Dodds AJ; Milliken ST; Tao H; Itescu S; Moore JJ; Ma DD; Graham RM, 2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, vol. 156, pp. 954 - 963, http://dx.doi.org/10.1016/j.ahj.2008.04.034
    Journal articles | 2008
    Dr John James Moore
    Kovacic JC; Moore JJ; Herbert AD; Ma DD; Boehm M; Graham RM, 2008, 'Endothelial progenitor cells, angioblasts, and angiogenesis - Old terms reconsidered from a current perspective', Trends in Cardiovascular Medicine, vol. 18, pp. 45 - 51, http://dx.doi.org/10.1016/j.tcm.2007.12.002
    Journal articles | 2008
    Dr John James Moore
    Wong LY; Moore J; Hill D; Brenner P; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Custing's syndrome can precipitate diabetes but mask non-Hodgkin's lymphoma', Medical Journal of Australia, vol. 188, pp. 262, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01608.x
    Journal articles | 2008
    Dr John James Moore
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases', Blood, vol. 112, pp. 164 - 164, http://dx.doi.org/10.1182/blood.v112.11.164.164
    Journal articles | 2008
    Dr John James Moore
    Farge-Bancel D; Labopin M; Tyndall A; Fassas A; Mancardi G-L; Van Laar J; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autogreffe de cellules souches hématopoïétiques (ASH) au cours de la sclérodermie systémique : 10ans d’expérience du groupe de travail de l’EBMT-EULAR sur les maladies auto-immunes (MAI)', La Revue de Médecine Interne, vol. 29, pp. S300 - S301, http://dx.doi.org/10.1016/j.revmed.2008.10.040
    Journal articles | 2008
    Dr John James Moore
    Wong LY; Moore JJ; Hill D; Brenner PC; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Cushing`s syndrome can precipitate diabetes but mask non-Hodgkin`s lymphoma', Medical Journal of Australia, vol. 188, pp. 262 - 262, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000255914800025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2008
    Dr John James Moore
    Potter V; Moore J, 2008, 'Randomised trials of graft versus host disease prophylaxis in haemopoietic stem cell transplantation', Reviews on Recent Clinical Trials, vol. 3, pp. 130 - 138, http://dx.doi.org/10.2174/157488708784223790
    Journal articles | 2007
    Dr John James Moore
    Brown DA; Moore JJ; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN, 2007, 'Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction', Arthritis Care & Research, vol. 56, pp. 753 - 764, http://dx.doi.org/10.1002/art.22410
    Journal articles | 2007
    Dr John James Moore
    Moore JJ; Nivison-Smith I; Goh K; Ma DD; Bradstock KF; Szer J; Durrant S; Schwarer AP; Bardy P; Herrmann RP; Dodds AJ, 2007, 'Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia', Biology of Blood and Marrow Transplantation, vol. 13, pp. 601 - 607, http://dx.doi.org/10.1016/j.bbmt.2007.01.073
    Journal articles | 2007
    Dr John James Moore
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Ma DD; Moore JJ; Simpson JM; Szer J, 2007, 'Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004', Biology of Blood and Marrow Transplantation, vol. 13, pp. 905 - 912, http://dx.doi.org/10.1016/j.bbmt.2007.04.003
    Journal articles | 2007
    Dr John James Moore
    Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, vol. 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
    Journal articles | 2007
    Dr John James Moore
    Kovacic JC; Macdonald PS; Freund J; Rasko J; Allan RM; Fernandes VB; Ma DD; Moore JJ; Graham RM, 2007, 'Profound thrombocytopenia related to G-CSF', American Journal of Hematology, vol. 82, pp. 229 - 230, http://dx.doi.org/10.1002/ajh.20787
    Journal articles | 2007
    Dr John James Moore
    Moore JD; Baichi M; Toledo R; Sitrin M, 2007, 'Pseudomelanosis of jejunum and ileum', Gastrointestinal Endoscopy, vol. 66, pp. 857 - 859, http://dx.doi.org/10.1016/j.gie.2007.01.030
    Journal articles | 2007
    Dr John James Moore
    Bryant A; Moore JJ; Dodds AJ; Milliken ST; Fay K; Ma DD, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', Haematologica - the Hematology Journal, vol. 92, pp. 516 - 516, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247176901661&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2007
    Dr John James Moore
    Kovacic JC; Ma DD; Tao H; Herbert AD; Moore JJ; Graham RM, 2007, 'Phenotypic characterization of CD133+cells suggests a potent hemangioblast population', Circulation Research, vol. 101, pp. E55 - E56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249155000025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2006
    Dr John James Moore
    Al-mashaleh M; Bak H; Moore JJ; Manolios N; Englert H, 2006, 'Resolution of sclerodermatous myocarditis after autologous stem cell transplantation', Annals of the Rheumatic Diseases, vol. 65, pp. 1247 - 1248, http://dx.doi.org/10.1136/ard.2005.048405
    Journal articles | 2006
    Dr John James Moore
    Anandacoomarasamy A; Moore J; McGill N; Manolios N; Englert H, 2006, 'Resolution of skin fibrosis and joint contractures in aggressive diffuse systemic sclerosis using autologous stem cell transplantation', APLAR Journal of Rheumatology, vol. 9, pp. 298 - 301, http://dx.doi.org/10.1111/j.1479-8077.2006.00218.x
    Journal articles | 2006
    Dr John James Moore
    Bai L; Deng Y; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2006, 'A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogenic haemopoietic stem cell transplant recipients', European Journal of Haematology, vol. 77, pp. 425 - 431, http://dx.doi.org/10.1111/j.1600-0609.2006.00729.x
    Journal articles | 2006
    Dr John James Moore
    Bryant A; Moore J, 2006, 'Rituximab and its potential for the treatment of rheumatoid arthritis', Therapeutics and Clinical Risk Management, vol. 2, pp. 207 - 212, http://dx.doi.org/10.2147/tcrm.2006.2.2.207
    Journal articles | 2006
    Dr John James Moore
    Pierson RN; Moore J; Merion RM; Azimzadeh AMI, 2006, 'ABO-incompatible lung transplantation', International Congress Series, vol. 1292, pp. 63 - 69, http://dx.doi.org/10.1016/j.ics.2006.03.052
    Journal articles | 2006
    Dr John James Moore
    Dodds AJ; Moore JJ; Goh K; Bradstock KF; Szer J; Nivison-Smith I; Ma DD, 2006, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic stem cell transplantation (SCT) for AML', Biology of Blood and Marrow Transplantation, vol. 12, pp. 27 - 27, http://dx.doi.org/10.1016/j.bbmt.2005.11.084
    Journal articles | 2006
    Dr John James Moore
    Carlin S; Moore JJ; Zaunders J; Kelleher T; Ma DD, 2006, 'Generation in vitro of T lineage cells from human adult haematopoietic stem cells', Clinical Immunology, vol. 119, pp. S160 - S160, http://dx.doi.org/10.1016/j.clim.2006.04.430
    Journal articles | 2006
    Dr John James Moore
    Carlin S; Moore JJ; Zaunders J; Kelleher AD; Ma DD, 2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, vol. 69A, pp. 399 - 400, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2005
    Dr John James Moore
    Ponchel F; Verburg R; Bingham SJ; Brown AK; Moore JJ; Protheroe A; Short K; Lawson C; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma DD; Van Laar J; Papadaki HA; Emery P; Isaacs JD, 2005, 'Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia', Arthritis Research and Therapy, vol. 7, pp. 80 - 92
    Journal articles | 2005
    Dr John James Moore
    Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; Van Laar J; Farge D; Andolina M; Arnold RH; Carreras E; Finke J; Kotter I; Kozak T; Lisukov I; Lowenberg B; Marmont A; Moore JJ; Saccardi R; Snowden J; van den Hoogen F; Wulffraat N; Zhou X; Tyndall A, 2005, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, vol. 35, pp. 869 - 879
    Journal articles | 2005
    Dr John James Moore
    David S; Englert H; Furlong TM; Rainer SP; Moore JJ, 2005, 'Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation', Bone Marrow Transplantation, vol. 35, pp. 629 - 630, http://dx.doi.org/10.1038/sj.bmt.1704832
    Journal articles | 2005
    Dr John James Moore
    Englert H; Katelaris C; McGill N; Schrieber L; Moore JJ, 2005, '`Grape-sultana` sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma', Internal Medicine Journal, vol. 35, pp. 436 - 437, http://dx.doi.org/10.1111/j.1445-5994.2005.00849.x
    Journal articles | 2005
    Dr John James Moore
    Ma DDF; Kovacic JC; Dodds A; Tao H; McDonald P; Feneley MP; Muller DW; Fruend J; Milliken S; Moore J; Itescu S; Graham RM, 2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, vol. 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
    Journal articles | 2005
    Dr John James Moore
    Bai L; Deng Y-M; Dodds AJ; Milliken S; Moore J; Ma DDF, 2005, 'A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.', Blood, vol. 106, pp. 5222 - 5222, http://dx.doi.org/10.1182/blood.v106.11.5222.5222
    Journal articles | 2005
    Dr John James Moore
    Johnston AJ; Dodds AJ; Ma DD; Milliken ST; Fay KC; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, vol. 106, pp. 5374 - 5374, http://dx.doi.org/10.1182/blood.v106.11.5374.5374
    Journal articles | 2005
    Dr John James Moore
    Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, vol. 106, pp. 134B - 134B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426100514&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2005
    Dr John James Moore
    Dodds AJ; Ma DD; Milliken ST; Fay K; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, vol. 106, pp. 429B - 429B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2005
    Dr John James Moore
    Bai L; Deng YM; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, vol. 106, pp. 389B - 389B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2004
    Dr John James Moore
    Snowden J; Passweg J; Moore JJ; Milliken ST; Cannell P; Van Laar J; Verburg R; Szer J; Taylor KM; Joske D; Rule S; Bingham S; Emery P; Burt R; Lowenthal RM; Durez P; McKendry R; Pavletic S; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks PM; Bredeson C; Tyndall A, 2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, vol. 31, pp. 482 - 488
    Journal articles | 2004
    Dr John James Moore
    Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, vol. 34, pp. 241 - 247, http://dx.doi.org/10.1038/sj.bmt.1704570
    Journal articles | 2004
    Dr John James Moore
    Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, vol. 103, pp. 2238 - 2247, http://dx.doi.org/10.1182/blood-2003-08-2765
    Journal articles | 2004
    Dr John James Moore
    Bingham S; Moore JJ, 2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, vol. 17, pp. 263 - 276, http://dx.doi.org/10.1016/j.beha.2004.05.002
    Journal articles | 2004
    Dr John James Moore
    Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, vol. 104, pp. 378B - 378B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225127701499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2004
    Dr John James Moore
    Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, vol. 104, pp. 371B - 371B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225127701474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2004
    Dr John James Moore
    Moore JJ; Johnston AM; David M; Sam MJ; Keith F; Tony D, 2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, vol. 104, pp. 354A - 354A
    Journal articles | 2004
    Dr John James Moore
    Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, vol. 8, pp. 2765 - 2765
    Journal articles | 2003
    Dr John James Moore
    Moore JJ; Snowden J; Pavletic S; Barr W; Burt R, 2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, vol. 32, pp. 53 - 56, http://dx.doi.org/10.1038/sj.bmt.1703944
    Journal articles | 2003
    Dr John James Moore
    Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, vol. 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982
    Journal articles | 2003
    Dr John James Moore
    Brooks P; Moore JJ; Tyndall A, 2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, vol. 6, pp. 79 - 82
    Journal articles | 2003
    Dr John James Moore
    Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, vol. 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071
    Journal articles | 2003
    Dr John James Moore
    Ponchel F; Papadaki H; Bingham S; Verburg R; Moore JJ; Protheroe A; McGonagle D; Snowden J; Van-Laar J; Markham A; Emery P; Isaacs D, 2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, vol. 62, pp. 164 - 164
    Journal articles | 2003
    Dr John James Moore
    Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, vol. 48, pp. 1464 - 1466
    Journal articles | 2002
    Dr John James Moore
    Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, vol. 46, pp. 2301 - 2309, http://dx.doi.org/10.1002/art.10495
    Journal articles | 2002
    Dr John James Moore
    Brooks P; Moore JJ; Tyndall A, 2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases
    Journal articles | 2001
    Dr John James Moore
    Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, vol. 28, pp. 8 - 12
    Journal articles | 2001
    Dr John James Moore
    Moore JJ; Tyndall A; Brooks P, 2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, vol. 15, pp. 711 - 726
    Journal articles | 2001
    Dr John James Moore
    Solomon B; Moore JJ; Arthur C; Prince HM, 2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384
    Journal articles | 2001
    Dr John James Moore
    Moore J; Brooks P, 2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, vol. 23, pp. 193 - 213, http://dx.doi.org/10.1007/s002810100059
    Journal articles | 2001
    Dr John James Moore
    Moore JJ; Brooks P, 2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213
    Journal articles | 2000
    Dr John James Moore
    Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, vol. 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103
    Journal articles | 1999
    Dr John James Moore
    Moore J; Coyle L; Isbister J; Roche J, 1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, vol. 29, pp. 88 - 89, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01596.x
    Journal articles | 1998
    Dr John James Moore
    Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, vol. 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536
    Journal articles | 1998
    Dr John James Moore
    Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, vol. 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526
    Journal articles | 1998
    Dr John James Moore
    Moore JJ; Isbister JP; Clifton-Bligh P; Eckstein RP, 1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, vol. 28, pp. 479 - 480, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02091.x
  • Reports | 2015
    Dr John James Moore
    Bhattacharyya A; Sahhar J; Milliken S; Ma D; Englert H; Tymms K; Danta M; Moore J, 2015, Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia, http://dx.doi.org/10.3899/jrheum.141234
  • Conference Abstracts | 2020
    Dr John James Moore
    Sharrack B; Saccardi R; Alexander T; Manuela B; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro P; Rovira M; Sormani MP; Snowden J, 2020, 'Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Toronto, CANADA, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, Toronto, CANADA, 25 April 2020 - 01 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058007199&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr John James Moore
    Saccardi R; Badoglio M; Burman J; Helbig G; Innocenti C; Kazmi M; Mancardi GL; Moore J; Muraro P; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2020, 'Beam vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, Vol. 55, pp. 37 - 38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000600556200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr John James Moore
    Fleming S; Venn N; Reynolds J; Nguyen U; Kwan J; Moore J; Yeung DT; Leahy MF; Greenwood M; Verner E; Bajel A; Berkahn L; Wei AH; Sutton R, 2019, 'Preliminary Minimal Residual Disease Analysis of the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 Study of Front-Line Blinatumomab with Chemotherapy in Adults with Ph Negative B-Cell Acute Lymphoblastic Leukaemia', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-132048
    Conference Abstracts | 2019
    Dr John James Moore
    Hendrawan K; Ford C; Khoo M; Zaunders J; Molloy T; Ma D; Moore J, 2019, 'CD39+T regulatory cell reconstitution in MS patients with different CD39 gene polymorphisms undergoing autologous HSCT: A Preliminary Study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Melbourne, AUSTRALIA, Vol. 26, pp. NP18 - NP18, presented at Conference of MS-Research-Australia, Melbourne, AUSTRALIA, 31 October 2019 - 01 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524556200062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr John James Moore
    Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-125154
    Conference Papers | 2019
    Dr John James Moore
    Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796
    Conference Papers | 2018
    Dr John James Moore
    Ford CD; Khoo M; Zaunders J; Massey J; Hendrawan K; Sutton I; Ma DDF; Moore JJ, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, Lisbon, PORTUGAL, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, PORTUGAL, 18 March 2018 - 21 March 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Dr John James Moore
    Ford C; Khoo M; Zaunders J; Hendrawan K; Massey J; Sutton I; Milliken S; Ma D; Moore JJ, 2017, 'Identification of the immune phenotypes associated with haematopoietic stem cell transplantation for Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, MS Res Australia, Sydney, AUSTRALIA, Vol. 23, pp. NP23 - NP23, presented at Progress in MS Research Conference, MS Res Australia, Sydney, AUSTRALIA, 11 October 2017 - 13 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Other | 2016
    Dr John James Moore
    Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, Erratum: Erratum to: “What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia” (Biol Blood Marrow Transplant (2016) 22 (731–743)), http://dx.doi.org/10.1016/j.bbmt.2016.04.023
    Conference Papers | 2016
    Dr John James Moore
    Kenneth B; Link E; Di Iulio J; Szer J; Marlton P; Wei A; Enno A; Schwarer AP; Lewis ID; D'Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn UH; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson WJ; Hertzberg MS; Deveridge SF; Rowlings PA; Mills AK; Gill DS; Bardy PG; Campbell L; Seymour JF, 2016, 'Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival', in BLOOD, AMER SOC HEMATOLOGY, San Diego, CA, presented at 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, 03 December 2016 - 06 December 2016, http://dx.doi.org/10.1182/blood.V128.22.338.338
    Conference Abstracts | 2016
    Dr John James Moore
    Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Greenwood M; Moore J; Hertzberg M; Larsen S; Kwan J; Brown L; Hogg M; Huang G; Tan J; Gifford G; Kerridge I, 2016, 'Complementary and Alternative Medicine Therapy (CAM) Use by Allogeneic BMT Survivorship Patients', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, Honolulu, HI, Vol. 22, pp. S476 - S476, presented at BMT Tandem Meetings, Honolulu, HI, 18 February 2016 - 22 February 2016, http://dx.doi.org/10.1016/j.bbmt.2015.11.1091
    Conference Papers | 2014
    Dr John James Moore
    Oliveira MC; Labopin M; Henes J; Moore J; Del Papa N; Stanciu R; Sakellari I; Schroers R; Scherer HU; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Snowden JA; Farge D, 2014, 'Does Ex Vivo CD34+Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243502176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr John James Moore
    Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie DS, 2014, 'The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after Relapse', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, Grapevine, TX, pp. S38 - S39, presented at BMT Tandem Meetings, Grapevine, TX, 26 February 2014 - 02 March 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331155400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr John James Moore
    Kumarasinghe G; Lavee O; Nivison-Smith I; Parker A; Malouf M; Keogh A; Milliken S; Dodds A; Plit M; Hayward C; Ma D; Fay K; Joseph J; Kotlyar E; Havryk A; Jabbour A; Glanville A; Macdonald P; Moore J, 2014, 'Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, San Diego, CA, pp. S84 - S84, presented at 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, San Diego, CA, 10 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/j.healun.2014.01.260
    Conference Papers | 2013
    Dr John James Moore
    Ibrahim K; Moore J; Horne A, 2013, 'Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, Salt Lake City, UT, pp. S184 - S184, presented at BMT Tandem Meetings, Salt Lake City, UT, 13 February 2013 - 17 February 2013, http://dx.doi.org/10.1016/j.bbmt.2012.11.179
    Conference Papers | 2013
    Dr John James Moore
    Khoo M; Carlin S; Lutherborrow M; Ma D; Moore J, 2013, 'GENE ARRAY ANALYSIS OF HUMAN HEMATOPOIETIC STEM CELLS REVEALS ASSOCIATION BETWEEN AGE, ALTERED SIGNALING AND LOSS OF LYMPHOCYTE POTENTIAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, Vienna, AUSTRIA, pp. S33 - S33, presented at 42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), Vienna, AUSTRIA, 22 August 2013 - 25 August 2013, http://dx.doi.org/10.1016/j.exphem.2013.05.130
    Conference Papers | 2013
    Dr John James Moore
    Kumarasinghe G; Lavee O; Parker A; Keogh A; Hayward C; Kotlyar E; Jabbour A; Havryk A; Malouf M; Plit M; Glanville A; Macdonald P; Moore J, 2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, Montreal, CANADA, pp. S254 - S254, presented at 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Montreal, CANADA, 24 April 2013 - 27 April 2013, http://dx.doi.org/10.1016/j.healun.2013.01.657
    Conference Papers | 2007
    Dr John James Moore
    Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Ma DD; Tao H; Freund J; Milliken ST; Dodds AJ; Moore JJ; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in Circulation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 2669 - 2670, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, Florida, USA, 04 November 2007 - 07 November 2007
    Conference Papers | 2007
    Dr John James Moore
    Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Orlando, FL, pp. 591 - 592, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, FL, 04 November 2007 - 07 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250394302670&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

Media